Topics

Articles

Invests $5 million to upgrade manufacturing processes


ACC supports both clinical and commercial viral vector production

Expansion project addresses assay development demands

Organization’s PAI portfolio boosts drug R&D, process development for pharma manufacturers

Project is centered around drug substance manufacturing

P4 is partially operational in under two years

Strategies to boost the reproducibility and traceability of cell and gene therapies for more effective clinical studies and commercialization

A conversation with dangerous goods expert Jay Johnson

Biopharma company's 100,000 square-foot California center will house its blood cancer treatments  

Designation is powered by CDMO’s sustainability focus 